McKesson (MCK) vs DataMeds AI (MEDS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
McKesson is the larger company by market cap ($108.46 billion vs $9.6 million), about 11257.8 times the size. McKesson pays a dividend yielding 0.35%, while DataMeds AI does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MCK | MEDS |
|---|---|---|
| Share price | $930.25 | $3.40 |
| Market cap | $108.46B | $9.63M |
| 1-day change | +2.19% | +18.06% |
| YTD return | +13.41% | — |
| 1-year return | +23.09% | — |
| 5-year return | +345.87% | — |
| P/E ratio (TTM) | 24.93 | — |
| Forward P/E | 18.43 | — |
| EPS (TTM) | $37.31 | $-46.68 |
| Dividend yield | 0.35% | 0.00% |
| Annual dividend | $3.28 | $0.00 |
| Revenue (latest FY) | $403.43B | — |
| Revenue growth (YoY) | +12.36% | — |
| Net income (latest FY) | $4.76B | — |
| Gross margin | 3.61% | — |
| Operating margin | 1.54% | — |
| Net margin | 1.18% | — |
| 52-week high | $999.00 | $73.00 |
| 52-week low | $723.68 | $0.823 |
| Distance from 52-week high | -6.88% | -95.34% |
| Analyst consensus | buy | — |
| Avg. price target upside | +5.06% | — |
| Average volume | 922.54K | 5.82M |
| Shares outstanding | 116.59M | 2.83M |
| Employees | 41,600 | — |
| Sector | Health Care | Healthcare |
| Industry | Other Pharmaceuticals | Medical Distribution |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 11257.8 times larger than DataMeds AI by market value ($108.46B vs $9.63M).
- The two companies sit in different sectors: McKesson in Health Care and DataMeds AI in Healthcare.
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
About DataMeds AI
MEDS stock →DataMEDS AI, Inc. operates as a health IT company in the United States.
Healthcare · Medical Distribution
MCK vs MEDS FAQ
Which is bigger, McKesson or DataMeds AI?
McKesson (MCK) is larger, with a market capitalization of $108.46B compared with $9.63M for DataMeds AI (MEDS).
Which pays a higher dividend, McKesson or DataMeds AI?
McKesson pays a dividend yielding 0.35%, while DataMeds AI does not currently pay a regular dividend.
Are McKesson and DataMeds AI in the same industry?
No. McKesson is in the Health Care sector, while DataMeds AI is in Healthcare.